A Antabuse, Antabus, Disulfiram CEP of the European Pharmacopoeia monograph is often referred to as a Antabuse, Antabus, Disulfiram Certificate of Suitability (COS). The purpose of a Antabuse, Antabus, Disulfiram CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Antabuse, Antabus, Disulfiram EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Antabuse, Antabus, Disulfiram to their clients by showing that a Antabuse, Antabus, Disulfiram CEP has been issued for it. The manufacturer submits a Antabuse, Antabus, Disulfiram CEP (COS) as part of the market authorization procedure, and it takes on the role of a Antabuse, Antabus, Disulfiram CEP holder for the record. Additionally, the data presented in the Antabuse, Antabus, Disulfiram CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Antabuse, Antabus, Disulfiram DMF.
A Antabuse, Antabus, Disulfiram CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Antabuse, Antabus, Disulfiram CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of Antabuse, Antabus, Disulfiram suppliers with CEP (COS) on PharmaCompass.